Join
Live feed
·
PRReleasevia Quantisnow
TuHURA Biosciences Inc. logo

TuHURA Biosciences Receives Key U.S. Patent for its Groundbreaking Delta Opioid Receptor (DOR) Antibody Drug Conjugate (ADC) Technology

ByQuantisnow·Wall Street's wire, on your screen.
HURA· TuHURA Biosciences Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track HURA (TuHURA Biosciences Inc.) and more on Quantisnow.